The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.
The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.
The resistance of advanced cases of melanoma to existing treatment modalities and the rapid rise in its incidence 1,2 underscore the importance of acquiring a better understanding of the pathogenesis of this disease. Research in this area has identified alterations that disrupt key tumor-suppressor and oncogene pathways during melanoma formation. The end results of these modifications include inhibition of the Rb tumor-suppressor pathway 3 , activation of the mitogen-activated protein kinase (MAPK) pathway 4 and activation of signaling pathways downstream of certain receptor tyrosine kinases 5 . Many of these changes, originally discovered through examination of tumor biopsies, have been functionally validated using experimental models 6 .
Melanoma can progress rapidly to metastatic disease. Widespread metastatic dissemination with relatively small (or undetectable) primary tumors is not an uncommon clinical occurrence [7] [8] [9] . In principle, this metastatic propensity might be due to peculiarities in the oncogenic mutations sustained during melanoma development or to extrinsic factors, such as the ability of ultraviolet radiation to induce melanoma-specific DNA lesions. Alternatively, melanocytes might be intrinsically predisposed, as a result of their differentiation program, to having invasive and metastatic traits after neoplastic transformation 10 . Despite the importance of distinguishing between these two fundamentally different scenarios, the inability to characterize fully the genetic lesions present in established cancer cell lines has precluded attempts to ascribe their tumor phenotypes to either differentiationor mutation-specific causes.
Dermal melanocytes arise from a uniquely migratory embryonic cell population called the neural crest. Neural crest cells are specified at the dorsal side of the neural tube during development; cells of this lineage then migrate throughout the embryo and give rise to numerous differentiated cell types, including dermal melanocytes 11 . The derivation of cutaneous melanomas from the migratory neural crest cell population supports the intrinsic predisposition hypothesis described above. Elements of the neural crest molecular circuitry responsible for migratory behavior during development might be reactivated during melanoma pathogenesis.
To examine the effects of cell type-specific factors on melanoma phenotypes, we used an experimental protocol that enables the neoplastic transformation of primary human cells by introducing a defined set of genetic elements 12 . This system uses the Simian Virus 40 early region (SV40ER), which encodes the viral large T (LT) and small T (st) oncoproteins, in conjunction with a gene encoding the catalytic subunit of the telomerase holoenzyme (hTERT) to immortalize primary human cells; the resulting immortalized cells are then transformed introducing a ras oncogene. Because this procedure generates cancer cell lines transformed with an identical set of genes, variations in tumor phenotypes arising from genetic differences between cancer cell lines are effectively minimized. A variety of human cell types transformed in this manner generate localized tumors in the absence of metastasis [12] [13] [14] [15] . We applied this technique to primary human melanocytes and uncovered distinctive behaviors of transformed melanocytes that help to explain the highly malignant phenotype associated with many human melanomas.
RESULTS

Melanocyte immortalization and transformation
To immortalize primary human melanocytes, we used retrovirus infection to introduce cDNAs encoding SV40ER and hTERT into the cells. After this genetic modification, the melanocytes proliferated indefinitely in culture (data not shown) but did not form either anchorage-independent colonies in soft agar or tumors when injected subcutaneously into immunocompromised mice ( Fig. 1 and Table 1) . We then introduced an oncogenic Ras protein (RasG12V) into the immortalized melanocytes, yielding Mel-STR cells, and observed that RasV12 efficiently transformed these cells, as indicated by their ability to form colonies in suspension culture and tumors in vivo ( Fig. 1 and Table 1) .
Several tyrosine kinase receptors that signal through the Ras-MAPK pathway are also implicated in melanomagenesis. In particular, melanoma cell lines frequently show autocrine stimulation provoked by hepatocyte growth factor (HGF) secretion 16 , and c-Met, the receptor for HGF, is frequently upregulated during melanoma progression 17, 18 . To test whether activation of the HGF-c-Met signaling loop can provide the proliferative signal for transformation, we introduced a constitutively active form of the c-Met receptor (TPRMet) 19 into immortalized human melanocytes.
TPR-Met was able to substitute for RasV12 in enabling the melanocytes to become transformed, as indicated by the ability of these Mel-STM cells to form suspension colonies in vitro and tumors in vivo (Fig. 1c) . In contrast, ectopic overexpression of HGF, which generates a c-Met autocrine growth-stimulatory loop, did not transform the immortalized melanocytes (Fig. 1c) . Hence, HGF overexpression increased the in vitro proliferation of the melanocytes (data not shown) and increased survival of minute colonies in soft agar (Fig. 1c) but did not result in tumor formation in vivo (Fig. 1c) . Vector-puro Fig. 1e and Supplementary  Fig. 1 online) . In contrast, human mammary epithelial cells transformed through the introduction of the identical set of genes (MEC-STR cells) were negative for MART-1 expression but positive for cytokeratins (Fig. 1e) .
Because the disruption of adherens junctions frequently accompanies melanoma progression, we examined the expression and localization of E-cadherin and b-catenin in the melanoma tumor sections. Mel-STR melanomas, unlike normal melanocytes, did not express E-cadherin and had weak membranous and cytoplasmic staining for b-catenin ( Supplementary Fig. 2 online) . Staining for the SV40 LT antigen showed that regions of the tumors contained cells that did not express the LT protein and were therefore composed of recruited stromal cells of murine origin ( Supplementary Fig. 2 online). Histological examination showed that these latter cells were frequently associated with regions of inflammation and necrosis and were, according to several criteria, largely neutrophils (data not shown).
Transformed melanoma cells form metastatic tumors in vivo
We undertook an extensive anatomical analysis at necropsy of the organs of melanoma-bearing mice to determine whether macroscopically visible metastases developed after subcutaneous injection of Mel-STR melanoma cells. To facilitate visualization of metastases in these mice, we used Mel-STR cells into which green fluorescent protein (GFP) had been introduced using a retroviral vector. We killed the mice when they appeared moribund (B6-8 weeks after the initial injection of transformed cells in most mice).
We observed numerous mice with widespread metastatic dissemination. We observed metastatic nodules in 92% of mice bearing Mel-STR tumors, most commonly in the lungs (92%) and lymph nodes (29%) but also in the liver (27%), spleen (22%) and small bowel (12%; Fig. 2 and Table 1 ). In general, the histology of metastatic growths resembled that of primary tumors. In cases where mice bore metastases to the liver, spleen or small bowel, metastatic burden was also invariably present in the lungs, raising the possibility that lung metastases may disseminate additional metastases to other organs.
Histological examination of metastasis-bearing lungs showed that metastatic melanomas frequently encapsulated and grew along the lung vasculature (Fig. 2) . Metastasis-associated lung vessels invariably had vasculitis and fibrinoid necrosis. In certain cases, we also observed melanoma cells in the lumina of blood vessels. In such cases, we frequently observed tumor fibrin thrombi in the vessel lumina. The vascular association of metastatic growths suggested a hematogenous route of dissemination.
The lymph node metastases mentioned above were located adjacent to the growing tumor mass, suggesting that the affected nodes were associated with the lymphatic drainage from the site of implantation. In a subset of mice, we also observed Mel-STR metastases in the axillary lymph nodes. Furthermore, in cases of axillary lymph node metastasis, the growths were observed exclusively (in all eight cases; Table 1 ) on the side of the mouse ipsilateral to the original site of injection. This pattern of growth parallels the flow of the lymphatic fluid, suggesting that the melanoma cells reach the axial lymph node through a lymphatic rather than hematogenous route.
Although intestinal metastases are rarely observed in cancers that arise outside the peritoneal cavity, a peculiar aspect of melanoma is its tendency to metastasize to the small bowel 20, 21 . This behavior was recapitulated in our experimental model; 11% of injected mice had visible metastatic nodules on the surface of the small bowel ( Fig. 2 and Table 1 ). Moreover, in a small number of cases, we observed metastatic melanoma cells invading the small bowel lumen (Fig. 2h) . Therefore, with high penetrance, the metastatic spectrum of Mel-STR cells paralleled that observed in human individuals with melanoma.
In stark contrast to these observations, we very rarely observed metastatic nodules in mice bearing subcutaneous BJ-STR or MEC-STR tumors ( Table 1) resultant tumors to metastasize. Because these primary human cell types were all transformed in vitro by introducing an identical set of genes, these observations indicate that the unique ability of transformed melanocytes to generate metastatic nodules efficiently is, in part, a consequence of their pre-existing differentiation program.
Clonal and genomic analysis of metastatic nodules
The short latency in the appearance of metastases after introduction of the melanoma cells into mice, together with the large number of microscopic and macroscopic metastases that we observed, suggested that many cells in the polyclonal population of transformed melanocytes already possessed the ability to form metastases before they were introduced into mouse hosts. Nonetheless, it remained formally possible that metastasis only occurred in vivo after rare metastasisprone cells arose in the primary tumor cell population. To address this issue, we undertook a clonal analysis of the disseminated metastases arising in single mice in vivo.
We dissected individual metastatic nodules that arose in single Mel-STR-injected mice and dissociated the tissue fragments into single cells by enzyme treatment. We then plated the heterogeneous cell populations (comprising both metastatic human tumor cells and mouse stromal cells) on tissue culture dishes and selected the melanoma cells using a drug marker that had been introduced by retroviral infection into the tumor cells during the initial transformation process. This procedure allowed us to obtain pure tumor cell populations, each of which was derived from a single metastatic nodule in vivo. Because retrovirus infection leads to quasirandom insertion of proviral sequences into host cell genomes, we were able to use Southern-blot analysis 22 to identify the provirus integration sites in the ancestral clone(s) from which the various Mel-STR populations were derived.
Thus, we isolated genomic DNA from each of the metastatic nodulederived tumor cell populations and carried out Southern-blot analysis to probe for the GFP sequence.
The continuous distribution in the sizes of cleaved DNA fragments derived from the parental transformed cells demonstrated the extensive polyclonality of the Mel-STR population immediately before injection in vivo (Fig. 3a) . Upon examination of metastatic Mel-STR nodules, we observed at least ten distinct cell clones among the metastases of two mice that had been injected with the same polyclonal population of transformed melanocytes (Fig. 3a) . Because the various clones were identified by examining a small number of nodules relative to the total metastatic burden, a large number of additional cell clones must have been present among the metastases of these mice. In support of this idea, genomic DNA obtained directly from the entire lung of one metastasis-laden mouse had a continuous distribution of DNA fragments, indicating that numerous distinct clones of metastatic tumor cells were present in the lung (Fig. 3a) . This continuous distribution of integrant sizes was similar to that observed in the starting population of injected cells, indicative of extensive clonal heterogeneity among the metastatic Mel-STR cells.
In addition to the clonal analyses, we used array comparative genomic hybridization (CGH) to interrogate directly the genomes of metastatic nodules to determine whether they carried alterations in DNA copy number relative to the primary tumors. We observed no substantial alterations in DNA copy number in six independent nodules isolated from three distinct organs relative to the primary tumor DNA. This result indicates that, at the level of resolution afforded by the array CGH assay, genomic alterations sustained at the site of primary tumor growth were not responsible for enabling Mel-STR cell metastasis. 
A R T I C L E S
Mel-STR tumors rapidly seed metastatic cells to secondary organs To examine further the metastatic phenotype of the transformed melanoma cells, we determined the stage of tumor growth at which metastatic Mel-STR cells were seeded into secondary organs. Accordingly, we surgically resected primary Mel-STR tumors from agematched cohorts of mice at specific times after injection (18, 28 or 44 d) and examined the mice for metastatic growths at the endpoint of the experiment (44 d). To ensure full resection of the primary melanomas, we removed a 0.5-cm margin of skin around each tumor during the surgery and confirmed the absence of melanoma cells by histological examination of the adjacent skin (data not shown). Even in mice in which the primary tumor was removed just 18 d after injection (mean tumor weight ¼ 400 mg), numerous metastatic nodules could be seen in the lungs (5 of 5) at the endpoint of the experiment (Fig. 3c,d ). Mice whose primary tumors were resected 28 d after injection (mean tumor weight ¼ 600 mg) also developed extensive lung metastases (Fig. 3c,e) .
Taken together with the results of the clonal analyses, these observations enabled us to estimate a lower bound on the frequency with which metastasis-enabling alterations must be occurring in vivo in order for the Mel-STR cells to acquire the ability to metastasize after their introduction in vivo. This frequency, B1 in 100, is several orders of magnitude greater than the estimated frequencies per cell generation of gene mutation (Supplementary Note online). Therefore, in conjunction with the array CGH data, these data suggest that it is unlikely that additional genetic alterations beyond those initially introduced during the transformation protocol were required in vivo to enable the injected Mel-STR cells to metastasize.
Slug is expressed in melanocytes before transformation
These results indicated that the differentiation program of melanocytes could cooperate with oncogenic lesions to uniquely predispose their transformed counterparts to forming tumors that metastasize, when compared with fibroblasts and epithelial cells transformed with identical genes. Because the process of cancer cell invasion bears numerous cellular and molecular similarities to neural crest cell migration in the developing embryo, and given the known derivation of dermal melanocytes from the neural crest, we hypothesized that elements of the motilityassociated molecular program mediating neural crest cell migration may contribute to melanoma metastasis.
Genes of the Snail superfamily are implicated in both promoting cancer cell invasiveness 23 and governing neural crest cell migration 24 . Although Snail was not substantially expressed in Mel-STR cells, the related transcription factor Slug was expressed at both the mRNA and protein levels (data not shown and Fig. 4a ). Slug expression was also observed in nontumorigenic, immortalized melanocytes. This finding led us to use expression arrays to examine Slug mRNA levels in benign human nevus samples obtained from individuals who did not have melanoma. We observed that benign nevi expressed Slug mRNA and, moreover, that expression of the Slug transcript in these samples correlated significantly (P o 0.01) with genes that are essential for neural crest cell or melanoblast migrations during development (Fig. 4b,c) . Expression of the neural crest migration-associated genes encoding Slug, endothelin receptor B (EDNRB), ERBB3 and CD44 was highly . Random lung sections were stained with a humanspecific vimentin antibody, and the area of brown color corresponding to stained Mel-STR cells was quantified using NIH Image software 35 .
correlated in adult nevus samples [24] [25] [26] [27] [28] . These findings indicated that components of an embryonic differentiation program involved in neural crest cell motility and migration were expressed in benign melanocytic lesions before neoplastic transformation.
Slug is essential for Mel-STR melanoma metastasis in vivo
We used retrovirus short interfering RNA (siRNA)-mediated inhibition to examine whether the expression of Slug, a master regulator of neural crest cell specification and migration, contributed to the metastatic ability of Mel-STR melanoma cells. We designed three independent retrovirus siRNAs directed against Slug (siSlug1-siSlug3) and stably introduced them into Mel-STR cells. As independent controls, we also introduced siRNAs against GFP (siGFP2) and luciferase (siLuc) into the same cell population. Using quantitative RT-PCR, we determined that siSlug1 and siSlug2 reduced endogenous Slug mRNA levels by B66%, whereas siSlug3 reduced endogenous mRNA levels by 80% (Fig. 4d) . We observed essentially identical levels of relative reduction in Slug mRNA transcript level when we introduced the same vectors into Mel-STV cells (Fig. 4d) .
To test whether reduction in Slug levels affected melanoma growth or progression, we introduced Mel-STR+siSlug3 cells, as well as two control lines (Mel-STR+siGFP2 or Mel-STR+siLuc cells), subcutaneously into immunodeficient mice. Slug inhibition resulted in a slight decrease in primary tumor growth rates (Fig. 4e) . We observed no differences in the histologies of the primary tumors that developed in the Mel-STR+siSlug3 line versus the control lines (data not shown).
In contrast, there was a marked reduction in the incidence of metastasis when primary tumor cells experiencing Slug inhibition were seeded in host mice. Metastatic lung tumor burden in the MelSTR+siSlug3 tumors was reduced by more than tenfold when compared with control Mel-STR+siGFP2 or Mel-STR+siLuc tumors (Fig. 4f) , as evaluated by staining lung tissue sections for the Mel-STR-specific marker human vimentin and then quantifying the stained area in random fields using NIH Image software (Supplementary Fig. 1 online) . To control for differences in primary tumor growth rates, we timed the killing of mice so that the average primary tumor burden in the two experimental groups was comparable (Fig. 4f) . These results indicate that Slug is a key component of the metastatic program in Mel-STR melanoma cells.
DISCUSSION
A fundamental feature of human melanoma is its tendency to metastasize to numerous organs throughout the body, but very few animal models recapitulate this essential aspect of the disease. Here we showed that human dermal melanocytes, transformed by the introduction of SV40ER, hTERT and RasG12V, can form primary tumors that are invasive and highly metastatic to secondary sites in the body. Moreover, the anatomical sites to which these melanoma cells metastasized are analogous to those observed in humans with melanoma. To our knowledge, this is the first human melanoma model with multiorgan metastases from a subcutaneous site.
Introduction of the identical set of genes into human epithelial and fibroblast cells has repeatedly resulted in localized tumor formation without apparent metastatic dissemination. Implementation of an isogenic transformation protocol controls for the possibility that oncogene-specific differences are responsible for the various cancer phenotypes observed after experimental conversion of primary human epithelial, fibroblast and melanocyte cells to a neoplastic state. Our results therefore indicate that the rapid progression of human melanomas to a metastatic state can be attributed in part to lineage-specific factors associated with the melanocyte differentiation program.
The commonly observed presence of nevus cell aggregates in human lymph nodes [29] [30] [31] supports the idea that normal melanocytes before transformation express a differentiation program that includes factors capable of promoting migratory behavior. These are characterized by clusters of histologically normal melanocytes detected in the capsule of lymph nodes, particularly those from the axillary, cervical and inguinal regions. This unique clinical observation, made in the absence of any malignant histology, suggests that dermal melanocytes do possess latent migratory abilities.
Our results validate the previously untested speculation 9 that the particularly aggressive nature of melanomas is ascribable to the derivation of dermal melanocytes from the embryonic neural crest. By controlling for oncogene-specific differences, our experiments show that the differentiation program of normal melanocytes can collaborate with oncogenic lesions to predispose their transformed derivatives to forming invasive and metastatic tumors. This idea is supported by analysis of microarray data from benign human nevus tissues, which shows coregulated expression of genes important for neural crest cell migrations during development, before neoplastic transformation of melanocytes. Moreover, one of these genes, encoding the neural crest cell transcription factor Slug, has a functional role in the metastatic spread of Mel-STR melanoma cells.
Our results do not address whether Slug expression is sufficient to enable melanoma metastasis. The multistep nature of metastasis makes it unlikely that a single factor can orchestrate this complex process. Moreover, the fact that Slug is expressed in benign melanocytic lesions implies that acquisition of its expression after transformation is not the single pathogenic event that enables metastasis. Nevertheless, the pre-existing expression of Slug in benign precursor lesions may reduce the number of additional rate-limiting alterations required to enable metastasis after melanocyte transformation, relative to cancers arising from other cell types. These experiments indicate that lineage-specific factors associated with melanocyte differentiation can affect the tumorigenic and metastatic phenotype observed after neoplastic transformation.
METHODS
Tissue culture and cells. We obtained primary human melanocytes, derived from neonate foreskin, from Clonetics and the Yale Cell Culture Core Facility and maintained them in MGM-3 medium (Clonetics). We grew immortalized and transformed melanocyte cell lines in Dulbecco's modified Eagle medium with 5% fetal bovine serum (Mel-STR medium). Foreskin fibroblast (BJ-STR)-derived cell lines were previously described 12 and maintained in Dulbecco's modified Eagle medium and M199 medium (4:1), supplemented with 10% heat-inactivated fetal calf serum. We generated human mammary epithelialderived cell lines as previously described 13 and grew them in Dulbecco's modified Eagle medium and F12 medium (1:1) supplemented with EGF (10 ng ml À1 ), insulin (10 mg ml À1 ), hydrocortisone (1 mg ml À1 ) and 5% calf serum.
To generate the immortalized melanocyte cell line Mel-ST, we infected primary melanocytes with pBABE-LTg-zeo and pBABE-hTERT-hygro and then infected these immortalized melanocytes with pBABE-RasV12-puro, pBABE-TPR-met-puro or pBABE-HGF-puro retroviruses to generate Mel-STR, Mel-STM or Mel-STH cells, respectively. We infected GFP-labeled cells with pWZL-GFP-blast. For stable siRNA cell lines, we infected Mel-ST and Mel-STR (pWZL-RasV12-blast) with pLKO-puro short hairpin RNA vectors.
Retrovirus vectors and infections. We generated retroviral constructs for HGF and TPR-Met by cloning the full-length cDNA encoding human HGF or TPRMet (provided by G. Vande Woude, Van Andel Research Institute, Grand Rapids, Michigan, USA) into the pBabe-puro vector system 32 . Other pBABEbased vectors included LTg-zeo 13 , hTERT-hygro 33 and RasV12-puro (a gift from S. Lowe, Cold Spring Harbor Laboratories, New York, USA). PWZL-based vectors 32 used were RasV12-blast (subcloned from pBABE-RasV12-puro using BamHI-SalI sites) and GFP-blast (a gift from A. Orimo, Whitehead Institute, 
A R T I C L E S
Cambridge, Massachusetts, USA). For siRNA-mediated inhibition, we cloned three different siRNA sequences against human Slug (sequences available on request) into the pLKO lentiviral vector system (provided by S.A. Stewart, Washington University, St. Louis, Missouri, USA and W.C. Hahn, Dana-Farber Cancer Institute, Boston, Massachusetts, USA). siRNA sequences against GFP and luciferase were previously described 34 .
We created amphotropic retroviruses by transient cotransfection of 6-cm plates of 293T cells with 1 mg of appropriate packaging plasmid (pCL-10A1 (Imgenex) for moloney-based infections and DHR8.1:VSVG (9:1) for lentiviral infections) and 1 mg of carrier vector using FuGene 6 (Roche). We collected viral supernatants 48 h after transfection, passed them through a 0.4-mm filter and supplemented them with 8 mg ml -1 polybrene (Sigma) before infection.
RT-PCR. We isolated total RNA from tumor tissues or cell lines using TRIZOL reagent (Invitrogen) in accordance with the manufacturer's protocols. We carried out quantitative real-time RT-PCR analysis using the iCycler apparatus (Bio-Rad) and SYBR Green PCR Core Reagents System (Perkin-Elmer Applied Biosystems). We evaluated results using the iCycler IQ Real Time Detection System Software (Bio-Rad). Data were normalized to GAPDH expression. Primer sequences are available on request.
Western blotting. Western blotting was done using standard protocols. We used primary antibodies against LT antigen (Pab101, Santa Cruz), Ras (C-20; Santa Cruz), Slug (G-18; Santa Cruz) and b-actin (Abcam). We used goat antibodies to mouse (115-035-146) and to rabbit (111-035-144) conjugated with horseradish peroxidase as secondary antibodies (Jackson Immunoresearch).
Soft agar assays. We carried out soft agar assays as described 35 .
Mice and surgery. We purchased athymic nude mice from Taconic Laboratories (NCR nude, nu/nu). NOD/SCID mice were bred and maintained in-house. All mice were housed in a specific pathogen-free facility and were given autoclaved food and water ad libitum. For in vivo tumor experiments, we resuspended 10 6 cancer cells in 200 ml of medium and injected it subcutaneously into 10-to 12-week-old male NOD/SCID mice or 8-week-old irradiated athymic nude mice. Nude mice received 400 rad of g-radiation using a dual 137 Cesium source 1 d before injection. We monitored mice biweekly and measured tumor diameters using precision calipers. For in vivo metastasis experiments, we allowed primary tumors to grow for B7 weeks or until they reached a diameter of 2 cm. For tumor resection experiments, we allowed primary tumors to grow for 18 or 28 d and then anesthetized the mice using avertin (0.4-0.7 mg per g body weight) and excised the tumors under a dissection microscope using DeWecker microdissecting spring scissors and a hand-held cautery unit. We then monitored mice daily until the end of the experiment.
Southern-blot analysis. We microdissected fresh tumor tissue or metastatic nodules from organs of individual mice at necropsy under a dissection microscope ( Supplementary Fig. 3 online) . We minced tissue fragments and digested them for 3 h with agitation at 37 1C in culture medium (Dulbecco's modified Eagle medium plus 10% fetal bovine serum) containing collagenase (1 mg ml À1 ; Boehringer Mannheim), hyaluronidase (125 U ml À1 ; Sigma) and HEPES buffer (10 mM; Gibco). We plated dissociated cells in Mel-STR medium and selected them with puromycin (1 mg ml À1 ) for one week. We isolated genomic DNA from the nodule-derived tumor cell populations and purified it by phenol-chloroform extraction. We digested 15 mg of DNA with BamHI and carried out Southern blotting as described 36 . For the lung of mouse 305, we isolated genomic DNA from the entire metastasis-burdened organ as described above (in the absence of microdissection or culture) and used 30 mg for blotting. As a probe template, we used an 800-bp EcoRI fragment from pWZL-GFP to synthesize 32 P-labeled probe using the Rediprime II kit (Amersham).
Array CGH. We prepared whole-genome array CGH comprising 1,860 PAC and BAC clones as described 37 . We carried out labeling of melanoma genomic DNA, array CGH hybridization and image processing as previously described 38 with slight modification. We fragmented 500 ng each of cell line and normal female genomic DNA by DPNII digestion; labeled it by random priming (Bioprime Labeling System, Invitrogen) with Cy3-and Cy5-dUTP (Amersham), respectively; coprecipitated it with 50 mg of human cot-1 DNA (Life Technologies); and resuspended it in 60 ml of hybridization buffer (50% formamide, 10% dextran sulfate, 2Â saline sodium citrate (SSC), 4% SDS and 200 mg yeast tRNA). We denatured this mixture at 75 1C for 10 min and then incubated it at 37 1C for 60 min. Just before hybridization, we crosslinked the array slides by ultraviolet radiation. We placed a rubber cement dam around each array, added hybridization mix and placed the slide in a plastic slide holder, prewarmed to 37 1C, containing 200 ml of wash buffer (50% formamide, 2Â SSC) to prevent evaporation. We carried out hybridization at 37 1C for 48-72 h on a gently rocking platform. After hybridization, we immersed slides for 15 min at 48 1C in wash buffer and then washed them at 48 1C in 2Â SSC and 0.1% SDS for 30 min and in PN buffer (0.1 M sodium phosphate buffer and 0.1% Nonidet-P40 (pH 8.0)) at room temperature for 10 min. We then rinsed the slides in 2Â SSC and mounted them with DAPI (0.5 mM) in 90% glycerol and 10% phosphate-buffered saline for imaging using a 16-bit CCD camera. The Cy3, Cy5 and DAPI images were segmented and analyzed to determine Cy3-Cy5 ratios for each array element using custom software as described 39 . We determined BAC positions using the July 2003 freeze of the University of California Santa Cruz genome sequence assembly.
Visualization of GFP-labeled metastatic nodules. We captured whole-organ bright-field and fluorescence images using a Leica MZ 9.5 dissection microscope.
Immunohistochemistry. We carried out immunohistochemical analysis on formalin-fixed, paraffin-embedded tissues. We removed paraffin from 5-mm sections, rehydrated them through a graded alcohol series and subjected them to antigen retrieval procedures as described previously 40 . We incubated sections with mouse monoclonal antibodies against MART-1 (Ventana), pan-cytokeratin (Ventana), human E-cadherin (1:50 Santa Cruz), human b-catenin (1:50, Santa Cruz) or LT antigen (Pab101, Santa Cruz 1:50). We visualized immunocomplexes using the ABC peroxidase method (Vector Laboratories) and counterstained sections with hematoxylin.
Quantification of lung metastasis. We removed entire lungs from mice with subcutaneous melanomas and fixed them in 10% neutral-buffered formalin for at least 12 h. We carried out immunohistochemical analysis on lung tissues with a mouse monoclonal human-specific vimentin antibody, which specifically stains the human melanoma cells ( Supplementary Fig. 1 online) . We quantified the area of melanoma burden using NIH Image software in at least two separate hot-spot fields per lung, with at least ten lungs per cell line. Software procedures were detailed previously 41 .
RNA extraction and microarray hybridization. We surgically isolated benign nevi from normal humans and flash-froze them. We isolated mRNA using CsCl gradient centrifugation, fluorescently labeled them and then hybridized them on an Affymetrix U133A array (22,283 genes) in accordance with the manufacturer's protocol.
Neighborhood analysis. We carried out neighborhood analysis of Slug in a data set that consists of nine nevi samples. We selected genes whose expression pattern significantly correlated with Slug by nonparametric permutation testing using a previously described procedure 42 . First, we ranked all 22,283 genes according to their correlation coefficients with respect to the Slug expression profile. We then generated 1,000 random permutations of the Slug profile and, for each permutation, reranked the 22,283 genes according to correlation with the shuffled Slug profile. A histogram of the distribution of correlation coefficients among 1,000 permutations for CD44 is shown in Figure 4c . For any gene with a given rank in the original Slug correlation list, we determined how many of the 1,000 permuted correlation coefficients corresponding to the same rank (but not necessarily the same gene) were greater than or equal to the original, nonpermuted correlation coefficient. We then assigned a P value by dividing this quantity by the total number of permutations. This procedure for Slug in the data set of nine nevus samples identified 235 genes with P o 0.05 (31 with P o 0.01). 
